Delivery Order SPE2DB24D2205-SPE2DB25FEGUK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,389.00 to AmerisourceBergen Drug Corp for the supply of Buprenorphine 0.3 mg/ml vials. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for Buprenorphine 15 mcg 4s under a Firm Fixed Price contract valued at $1,353.60. The award, issued on April 24, 2025, with an ultimate completion date of May 21, 2025, represents a competitive, non-set-aside procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Buprenorphine 2 mg tablets in 30-count packages at a ceiling value of $1,442.88. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by September 15, 2025. The contract will be fulfilled from AmerisourceBergen's Pennsylvania facility, supporting...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.19 to AmerisourceBergen Drug Corp for the supply of Buprenorphine-Naloxone 12-3mg film strips (30-count packages) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 buprenorphine 2 mg tablets. The firm fixed price order is to be performed in Conshohocken, Pennsylvania from July 13-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the opioid addiction treatment medication to support the Agency's health services for service members and their families. No set aside designation or...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against their indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical). Valued at one thousand three hundred thirty dollars and fifty-six cents ($1,330.56), this order is for the supply of thirty (30) Buprenorphine-Naloxone 8-2mg films to support DLA Troop Support Medical programs. Performance will occur at Amerisourcebergen's facility located in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,431 to Amerisourcebergen Drug Corporation for buprenorphine 7.5 mcg/hr patches. The order is for a quantity of four shipments to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 30, 2023. No additional details were provided on the original solicitation or whether this delivery order is placed against an existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nalbuphine 100 mg/10 mL vials with a ceiling value of $1,366.25. This firm fixed-price, non-set-aside contract is classified as a delivery order and is scheduled for completion by September 9, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGUKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Buprenorphine 0.3 mg/mL vials with a ceiling value of $5,556.00. This is a firm fixed-price delivery order issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The award was not set aside and represents a competitive award to the prime contractor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling Defense Health Agency and military medical supply requirements across multiple therapeutic domains, positioning the company as a critical pharmaceutical distributor within the federal medical procurement system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/26/25 |